Literature DB >> 10613724

Partial pressure of ammonia versus ammonia in hepatic encephalopathy.

L Kramer1, B Tribl, A Gendo, C Zauner, B Schneider, P Ferenci, C Madl.   

Abstract

Ammonia is considered the major pathogenetic factor of cerebral dysfunction in hepatic failure. The correlation between total plasma ammonia and the severity of hepatic encephalopathy (HE), however, is variable. Because ammonia that is present in gaseous form readily enters the brain, the correlation with the grade of HE of the pH-dependent partial pressure of gaseous ammonia (pNH(3)) could be better than that of total arterial ammonia levels. To test this hypothesis, 56 cirrhotic patients with acute episodes of clinical HE (median age, 54 years; range, 21-75) were studied by clinical examination and by long-latency median-nerve sensory-evoked potentials (SEPs) N70 peak, an objective and sensitive electrophysiological measure of HE. pNH(3) was calculated from arterial blood according to published methods. The clinical grade of HE correlated (P <.001) with both pNH(3) and total ammonia, but correlation was stronger with pNH(3) (r =.79 vs.69, P =.01). A similar correlation was found for N70 peak latency (r =.71 with pNH(3) vs.64 with total ammonia, respectively, P =.08). In summary, arterial pNH(3) correlates more closely than total ammonia with the degree of clinical and electrophysiological abnormalities in HE. These findings support the ammonia hypothesis of HE and suggest that pNH(3) might be superior to total ammonia in the pathophysiological evaluation of HE.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10613724     DOI: 10.1002/hep.510310107

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  40 in total

1.  Helicobacter pylori infection is not associated with subclinical hepatic encephalopathy in stable cirrhotic patients.

Authors:  I A Scotiniotis; M R Lucey; D C Metz
Journal:  Dig Dis Sci       Date:  2001-12       Impact factor: 3.199

Review 2.  Blood ammonia levels and hepatic encephalopathy.

Authors:  Alan H Lockwood
Journal:  Metab Brain Dis       Date:  2004-12       Impact factor: 3.584

3.  Breath ammonia testing for diagnosis of hepatic encephalopathy.

Authors:  Suja DuBois; Sue Eng; Renuka Bhattacharya; Steve Rulyak; Todd Hubbard; David Putnam; David J Kearney
Journal:  Dig Dis Sci       Date:  2005-10       Impact factor: 3.199

Review 4.  Energy metabolism in brain cells: effects of elevated ammonia concentrations.

Authors:  Leif Hertz; Geeta Kala
Journal:  Metab Brain Dis       Date:  2007-12       Impact factor: 3.584

Review 5.  Signaling factors in the mechanism of ammonia neurotoxicity.

Authors:  M D Norenberg; K V Rama Rao; A R Jayakumar
Journal:  Metab Brain Dis       Date:  2008-12-23       Impact factor: 3.584

6.  Clinical utility of breath ammonia for evaluation of ammonia physiology in healthy and cirrhotic adults.

Authors:  Lisa A Spacek; Matthew Mudalel; Frank Tittel; Terence H Risby; Steven F Solga
Journal:  J Breath Res       Date:  2015-12-14       Impact factor: 3.262

7.  Current concepts in the pathophysiology and management of hepatic encephalopathy.

Authors:  R Todd Frederick
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-04

Review 8.  Brain edema in acute liver failure: mechanisms and concepts.

Authors:  Kakulavarapu V Rama Rao; Arumugam R Jayakumar; Michael D Norenberg
Journal:  Metab Brain Dis       Date:  2014-02-25       Impact factor: 3.584

Review 9.  The Role of RRT in Hyperammonemic Patients.

Authors:  Shruti Gupta; Andrew Z Fenves; Robert Hootkins
Journal:  Clin J Am Soc Nephrol       Date:  2016-05-19       Impact factor: 8.237

Review 10.  New concepts in the mechanism of ammonia-induced astrocyte swelling.

Authors:  M D Norenberg; A R Jayakumar; K V Rama Rao; K S Panickar
Journal:  Metab Brain Dis       Date:  2007-12       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.